Mirum Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Mirum Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -31.3 %, a 59.1% increase year-over-year.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -31.3 +45.3 +59.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -41 +61.3 +59.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -48.4 +82.8 +63.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.6 +112 +65.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -76.5 +196 +71.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -102 +294 +74.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -131 +364 +73.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -170 +736 +81.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -273 Jul 1, 2022 Sep 30, 2022
Q2 2022 -396 Apr 1, 2022 Jun 30, 2022
Q1 2022 -495 Jan 1, 2022 Mar 31, 2022
Q4 2021 -906 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.